European Respiratory Society
When do we treat hypercholesterolemia?
Contenu en anglais
Synthèse
Although the relationships between elevated total and low-density lipoprotein (LDL) cholesterol and coronary heart disease (CHD) are relatively well established and published treatment guidelines are available, clinicians face a number of complex issues when deciding whom to treat. Specific patient characteristics and potential risk factors, of which less is known, may influence treatment decisions. In this presentation, the current guidelines for treating patients with hypercholesterolemia are reviewed and therapeutic issues that must be considered when selecting patients for treatment are identified.
Prognia résume cette recommandation à des fins de consultation et d’enseignement. Il ne s’agit pas d’un avis médical. Vérifiez toujours la recommandation officielle et les protocoles locaux en vigueur avant de l’appliquer.
Supports pédagogiques
En bref
- Organisme
- European Respiratory Society
- Date de publication
- 1992
- Région
- International (Europe)
- Langue
- English
Autres recommandations en cardiologie
- Civil aviation and cardiology. Admission rules and follow-up of the technical flying personnel of TAP-Air PortugalEuropean Respiratory Society · 1992
- Optimising plasma lipids: public intervention versus high risk managementEuropean Respiratory Society · 1992
- ESC guidelines on dyslipidemia update 2025 : New recommendations for the practice
